Home / Health / GLP-1 Drugs Linked to Hair Loss Side Effect
GLP-1 Drugs Linked to Hair Loss Side Effect
27 Sep
Summary
- Up to 20% of GLP-1 users report hair shedding, often within the first year.
- Hair loss can be temporary telogen effluvium or more permanent pattern baldness.
- Proper nutrition, lower doses, and patience can help manage GLP-1 related hair loss.
Many individuals using GLP-1 receptor agonists for weight management or type 2 diabetes are experiencing hair loss. This side effect has gained attention, with research indicating that up to 20% of users report increased hair shedding. The hair loss typically appears within the first year of taking medications like semaglutide and tirzepatide.
The most common form is telogen effluvium, a temporary condition triggered by stressors like rapid weight loss, causing hair follicles to enter a resting phase and subsequently shed. A smaller percentage may experience exacerbated pattern baldness, a genetically influenced condition.
While temporary hair loss often resolves once the underlying cause is addressed and the body adapts, pattern baldness can be permanent. Factors such as high doses, rapid weight loss, and nutritional deficiencies can contribute to telogen effluvium. For pattern baldness, a biological link to the genes influencing GLP-1 response is suspected.
Preventative measures include ensuring adequate protein, iron, zinc, and biotin intake. If hair loss occurs, consulting a healthcare professional is advised to distinguish between temporary and permanent types. Treatments for pattern baldness may include minoxidil and finasteride, while nutritional support and patience are key for reversible shedding.
